Literature DB >> 23679084

No evidence of cardiomyopathy in spinal and bulbar muscular atrophy.

G Querin1, P Melacini, C D'Ascenzo, L Morandi, L Mazzini, V Silani, S Romito, J Mandrioli, M Raimondi, E Pegoraro, G Soraru'.   

Abstract

OBJECTIVES: Spinal and bulbar muscular atrophy (SBMA) is a lower motor neuron disease caused by a CAG repeat expansion within the androgen receptor (AR) gene. Toxic nuclear accumulation of mutant AR has been observed in tissues other than nervous system including cardiac muscle. Moreover, CAG polymorphism length within AR has been associated with an increased risk of heart disease.
MATERIALS AND METHODS: To test the hypothesis of the presence of cardiomyopathy in SBMA, a full cardiac protocol was applied to 25 SBMA patients.
RESULTS: Patients' age ranged between 32 and 75 years. Cardiologic examination, 12-lead ECG, and echocardiography showed no abnormalities other than those consistent with hypertensive heart disease. One patient showed frequent supraventricular premature beats in absence of other significant arrhythmias at the 24-h ECG Holter.
CONCLUSIONS: Our findings do not support the hypothesis of a primary cardiomyopathy in SBMA.
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  androgen receptor; heart; polyglutamine; spinal and bulbar muscular atrophy

Mesh:

Substances:

Year:  2013        PMID: 23679084     DOI: 10.1111/ane.12140

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  6 in total

1.  Only some patients with bulbar and spinal muscular atrophy may develop cardiac disease.

Authors:  Josef Finsterer; Claudia Stöllberger
Journal:  Mol Genet Metab Rep       Date:  2017-12-21

2.  The French national protocol for Kennedy's disease (SBMA): consensus diagnostic and management recommendations.

Authors:  Pierre-François Pradat; Emilien Bernard; Philippe Corcia; Philippe Couratier; Christel Jublanc; Giorgia Querin; Capucine Morélot Panzini; François Salachas; Christophe Vial; Karim Wahbi; Peter Bede; Claude Desnuelle
Journal:  Orphanet J Rare Dis       Date:  2020-04-10       Impact factor: 4.123

Review 3.  Molecular Mechanisms and Therapeutics for SBMA/Kennedy's Disease.

Authors:  Frederick J Arnold; Diane E Merry
Journal:  Neurotherapeutics       Date:  2019-10       Impact factor: 7.620

4.  Non-neural phenotype of spinal and bulbar muscular atrophy: results from a large cohort of Italian patients.

Authors:  Giorgia Querin; Cinzia Bertolin; Elisa Da Re; Marco Volpe; Gabriella Zara; Elena Pegoraro; Nicola Caretta; Carlo Foresta; Maria Silvano; Domenico Corrado; Massimo Iafrate; Lorenzo Angelini; Leonardo Sartori; Maria Pennuto; Alessandra Gaiani; Luca Bello; Claudio Semplicini; Davide Pareyson; Vincenzo Silani; Mario Ermani; Alberto Ferlin; Gianni Sorarù
Journal:  J Neurol Neurosurg Psychiatry       Date:  2015-10-26       Impact factor: 10.154

Review 5.  Biomarkers of Spinal and Bulbar Muscle Atrophy (SBMA): A Comprehensive Review.

Authors:  Giorgia Querin; Peter Bede; Veronique Marchand-Pauvert; Pierre-Francois Pradat
Journal:  Front Neurol       Date:  2018-10-10       Impact factor: 4.003

6.  Only some patients with bulbar and spinal muscular atrophy may develop cardiac disease.

Authors:  Josef Finsterer; Claudia Stöllberger
Journal:  Mol Genet Metab Rep       Date:  2017-11-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.